HC Wainwright & Co. analyst Yi Chen maintains Renalytix (NASDAQ:RNLX) with a Buy and lowers the price target from $30 to $15.
Citigroup’s $400M Q2 Expense Spike: Result of Job Cuts and Reduced Trading Activity, Says CEO
At a Morgan Stanley conference, Citigroup Inc's (NYSE: C) CEO Mark Mason said that recent job cuts at the firm would cost up to $400 million this quarter compared to the first three months of the year.